GPC1 and cancer: This high expression of charged proteinson the GPC-1+ cancer exosomes makes GFETs sensors suitable for accuratediscrimination between cancer and healthy samples, which is otherwisechallenging when other methods such as ELISA or Nanoflow are usedparticularly when the healthy and cancer plasma samples have the samelevel of GPC-1 exosome.